Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Papers of the Week
 Comments
Keywords:   any keywords all keywords
Comments By:     Select Commentator
Posted Date:   From
  To    
Sort By:  
   
 
  * Comments posted before 22 May 2002 cannot be searched or sorted by posted date. Enter keywords and/or commentator and click this button to search only these comments.
Search Results: Comments By= Calon, Frederic; Sort By= Posted Date
1 to 12 of 12 results
Calon F. on NEWS: Gammagard™ Misses Endpoints in Phase 3 Trial, We clearly need to wait until the release of the complete data before drawing conclusions.... 10 May 2013. 

Calon F. on NEWS: Can Transferrin Antibodies Safely Open the Blood-Brain Barrier?, The search for brain drug delivery vectors has not yielded much success. Therefore, the... 3 May 2013. 

Calon F. on PAPER: Min SW. et al., 2010, The debate continues about which key modifications turn tau into a neuron killer. This study by... 27 Sep 2010. 

Calon F. on NEWS: Sweet 16: Novel APP Processing Pathway and a New Biomarker?, A critical question indeed. We should answer that. The evaluation of cognitive function may lack... 28 Apr 2010. 

Calon F. on NEWS: Medical Foods—Fallback Option for Elusive AD Drug Status?, I think it would have been a major advantage to get Ketasyn/AC1202 FDA-approved as a drug.... 12 Nov 2009. 

Calon F. on PAPER: He C. et al., 2009, This paper from He et al. adds to the mounting evidence that omega-3 polyunsaturated fatty acids... 29 Jun 2009. 

Calon F. on Early-Onset Familial AD: Alzheimer Disease in Mid-life, I would like to thank Richard Bozanich for his toughtful comments. AD is often mistaken for... 22 Oct 2007. 

Calon F. on SITE POLL: What's the AD drug smith to do about the blood-brain barrier?, BBB Is Overrated; Any Molecule Can Be Engineered to Get In! Not a single drug on the... 29 Mar 2007. 

Calon F, Laurin D. on PAPER: Schaefer EJ. et al., 2006, The prospective study of Ernst Schaefer et al. suggests an interesting link between blood... 6 Dec 2006. 

Calon F. on NEWS: First Trial of Fish Fats Shows Promise for Early AD, To determine the efficacy of any drug, randomized clinical trials (RCTs) remain the gold... 14 Oct 2006. 

Calon F. on NEWS: Omega-3 Fatty Acid Target Identified in Neurite Extension, The recent paper of Frédéric Darios and Bazbek Davletov adds up to recent studies trying to... 17 Apr 2006. 

Calon F, Cole G, Frautschy S. on NEWS: Presenilins Work Overtime to Control Akt, Tau, and Aβ—n-3 Fatty Acids Aid and Abet, This report from Akbar and Kim adds to their earlier work in this area by providing compelling... 25 Jul 2005. 

1 to 12 of 12 results
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ALS Forum

The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
ALS Forum
Polls
 
Should the FDA be allowed to use data from overseas clinical trials?

Absolutely, we are running out of viable subjects in the U.S.
 9
 
Yes, so long as the data is reliable
 31
 
No, the trials are not as rigorous
 3
 
No, the data should be repeated in the U.S.
 5
 
No, the drug sponsors are just trying to cut corners
 3
 
Responses: 51
 
 
 
 
 
Archived Polls
 
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Forum Calendar

Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad